Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

People with Down syndrome often have skin issues and need regular check-ups for early treatment.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

TNF-alpha inhibitors can cause various immune-related skin issues.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

New therapies for rare skin diseases show promise but need more research.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Skin infections and eczema were most common in all ages, acne in teens and young adults, and nutritional skin problems and infestations in children.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

Children's skin diseases need special care and treatment.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Artificial hair implants can still cause side effects despite improvements.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

Sports influence skin condition names and help in diagnosis and treatment.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.